CN3799854
Expired
Amendment A1
To understand the safety and efficacy of the COVID-19 vaccines in cancer patients through the implementation of a study based on the NCI SeroNet study in Australia
$1.1M
Contract Value
Contract Details
- Contract ID
- CN3799854
- Status
- active
- Financial Year
- FY23
- Category
- Healthcare Services(UNSPSC: 85101700)
Key Dates
- Publish Date
- 27 Apr 2023
- Signed Date
- 28 July 2021
- Start Date
- 9 June 2021
- End Date
- 29 June 2024
- Duration
- 3 years, 1 month
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- TR
- Exemption Reason
- 10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.
Contract History
This contract has been amended 1 time. Currently showing amendment A1.
Original Contract
Published 28 July 2021 · 9 June 2021 to 29 June 2024
$390K
Amendment A1
Current
Published 27 Apr 2023 · 9 June 2021 to 29 June 2024
$1.1M
+$671K